The Journal of Nutritional Biochemistry
Volume 21, Issue 4 , Pages 261-267 , April 2010

Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet

  • Gisella Mutungi

      Affiliations

    • Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
    • ,
  • David Waters

      Affiliations

    • Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
    • ,
  • Joseph Ratliff

      Affiliations

    • Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
    • ,
  • Michael Puglisi

      Affiliations

    • Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
    • ,
  • Richard M. Clark

      Affiliations

    • Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
    • ,
  • Jeff S. Volek

      Affiliations

    • Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
    • Department of Kinesiology, University of Connecticut, Storrs, CT 06269, USA
    • ,
  • Maria Luz Fernandez

      Affiliations

    • Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
    • Department of Kinesiology, University of Connecticut, Storrs, CT 06269, USA
    • Corresponding Author InformationCorresponding author. Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA. Tel.: +1 860 486 5547; fax: +1 860 486 3674.

Received 2 June 2008 ,Revised 2 December 2008 ,Accepted 15 December 2008.

References 

  1. Expert Panel on Detection EaToHBCiA . Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285:2486–2497
  2. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007;176:1113–1120
  3. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein b in the prediction of coronary heart disease in men. Circulation. 2005;112:3375–3383
  4. Zambon A, Bertocco S, Virtturi N, Polentarutti V, Vianello D, Crepaldi G. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans. 2003;31:1070–1074
  5. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis. 1991;90:67–80
  6. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93:189–199
  7. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb. 1991;11:174–182
  8. Marcovina S, Packard CJ. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Int Med. 2006;259:437–446
  9. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarctin in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952
  10. Meisinger C, Loewel H, Mraz W, Koenig W. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J. 2005;26:271–278
  11. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard P, Dagenais G, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation. 1996;94:273–278
  12. Onat A, Ozhan H, Can G, Hergenc G, Karabulut A, Albayrak S. Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks. Anadolu Kardiyol Derg. 2007;7:128–133
  13. Clark RM, Herron KL, Waters D, Fernandez ML. Hypo- and hyper-response to egg cholesterol predicts lutein and beta-carotene plasma concentrations in men and women. J Nutr. 2006;136:601–607
  14. Furr HC, Clark RM. Intestinal absorption and tissue distribution of carotenoids. Nutr Biochem. 1997;8:364–377
  15. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28–40
  16. Mutungi G, Ratliff J, Puglisi M, Torres-Gonzalez M, Vaishnav U, Leite JO, et al. Dietary cholesterol from eggs increases HDL cholesterol in overweight men consuming a carbohydrate restricted diet. J Nutr. 2008;138:272–276
  17. Wood RJ, Volek JS, Liu Y, Shachter NS, Contois JH, Fernandez ML. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL and HDL subfraction distribution and size in overweight men. J Nutr. 2006;136:384–389
  18. Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW, et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem. 2005;51:1102–1109
  19. Ogawa Y, Fielding CJ. Assay of cholesteryl ester transfer activity and purification of a cholesteryl ester transfer protein. Methods Enzymol. 1985;111:274–285
  20. Hospattakar AV, Fairwell T, Ronan R, Brewer HB. Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects. J Biol Chem. 1984;259:318–322
  21. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49:755–765
  22. Hiukka A, Fruchart-Najib J, Leinonen E, Hilden H, Fruchart JC, Taskinen MR. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in Type 2 diabetes. Diabetologia. 2005;48:1207–1215
  23. Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard B. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status: relation to plasma triglyceride and apolipoprotein B concentration. Insulin Atherosclerosis Study (IRAS) investigators. Arterioscler Thromb Vasc Biol. 1997;17:64–71
  24. Seshadri P, Iqbal N, Stern L, Williams M, Chicano KL, Daily DA, et al. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med. 2004;117:398–405
  25. Westman EC, Yancy WS, Olsen MK, Dudley T, Guyton JR. Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int J Cardiol. 2006;110:212–216
  26. Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006;83:1025–1031
  27. Feinman R, Volek J. Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss. Nutr Met (Lond). 2006;3:24
  28. Herron KL, Lofgren IE, Sharma M, Volek JS, Fernandez ML. A high intake of dietary cholesterol does not result in more atherogenic LDL particles in men and women independent of response classification. Metab Clin Exp. 2004;53:823–830
  29. Greene CM, Waters D, Clark RM, Contois JH, Fernandez ML. Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population. Nutr Met. 2006;3:6
  30. Tailleux A, Duriez P, Fruchart JC, Clavey V. Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis. 2002;164:1–3
  31. Jahn CE, Osborne JC, Schaefer EJ, Brewer HB. In vitro activation of the enzymic activity of hepatic lipase by apo A-II. FEBS Lett. 1981;131:366–368
  32. Castenmiller JJM, West CE, Linssen JPH, van het Hof KH, Voragen AGJ. The food matrix of spinach is a limiting factor in determining the bioavailability of β-carotene and to a lesser extent of lutein in humans. J Nutr. 1999;129:349–355
  33. Voutilainen S, Nurmi T, Mursu J, Rissanen TH. Carotenoids and cardiovascular health. Am J Clin Nutr. 2006;83:1265–1271
  34. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:216–230
  35. Erdman JJ, Bierer T, Gugger E. Absorption and transport of carotenoids. In:  Canfield L,  Krinsky N,  Olson J editor. Carotenoids in Human Health. New York: NY Acad. Sci.; 1993;p. 76–86

☆ Supported by the Egg Nutrition Center/American Egg Board.

PII: S0955-2863(09)00003-5

doi: 10.1016/j.jnutbio.2008.12.011

The Journal of Nutritional Biochemistry
Volume 21, Issue 4 , Pages 261-267 , April 2010

Article Tools

* Image Usage & Resolution